|Other names||69,XXX 2n/3n mixoploidy, 3n syndrome, chromosome triploidy syndrome, diploid/triploid mixoploidy, triploidy, triploidy syndrome|
|A karyotype of a person with triploidy|
Triploid syndrome, also called triploidy, is a chromosomal disorder in which a fetus has three copies of every chromosome instead of the normal two. If this occurs in only some cells, it is called mosaic triploidy and is less severe.
Most embryos with triploidy miscarry early in development.
Signs and symptoms
Many organ systems are affected by triploidy, but the central nervous system and skeleton are the most severely affected:
Common central nervous system defects seen in triploidy include holoprosencephaly, hydrocephalus (increased amount of cerebrospinal fluid within the brain), ventriculomegaly, Arnold–Chiari malformation, agenesis of the corpus callosum and neural tube defects.
Triploid fetuses have intrauterine growth restriction beginning early in the pregnancy, as early as 12 weeks, and does not affect the head as severely as the body. Oligohydramnios, low levels of amniotic fluid, is common in triploid pregnancies. Placental abnormalities are common in triploidy. Most frequently, the placenta is enlarged and may have cysts within. In some cases, the placenta may be unusually small, having ceased to grow.
Triploidy may be suggested by dramatically elevated levels of serum alpha-fetoprotein. On obstetric ultrasonography, abnormalities of the skeleton, central nervous system, heart, abdomen, and kidneys are visible in the most severe cases beginning at 12-14 weeks of pregnancy. Placental abnormalities associated with a triploid pregnancy become visible at 12-14 weeks. Placentomegaly or intrauterine growth restriction are the typical findings that prompt evaluation for triploidy, though oligohydramnios may be the first sign in some cases. Placentomegaly is not pathognomonic for triploidy because in some cases, the placenta senesces.
Most fetuses with triploidy do not survive to birth, and those that do usually die within days. As there is no treatment for triploidy, palliative care is given if a baby survives to birth. If triploidy is diagnosed during the pregnancy, termination is often offered as an option due to the additional health risks for the mother (pre-eclampsia, a life-threatening condition, or choriocarcinoma, a type of cancer). Should a mother decide to carry until term or until a spontaneous miscarriage occurs, doctors will monitor her closely in case either condition develops.
- Erol O, Erol M, Karaca M (October 2013). "Complete chorioamniotic separation and persistence of a yolk sac associated with triploidy". Journal of Obstetrics and Gynaecology Canada. 35 (10): 914–6. PMID 24165059.
- Sanders, Roger C. (2002-01-01). Structural Fetal Abnormalities: The Total Picture. Mosby. ISBN 9780323014762.